Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$154.4M
+19.3% from 2023
Prescriptions
847K
$182.20 per claim
Patients
283K
126,132 prescribers
Total spending, 2024
$154.4M
$544.76 per patient
Medicare prescription drug plans paid $154.4M for Insulin Lispro Kwikpen U-100 in 2024, for 847,337 prescriptions and refills to 283,389 patients (up 19.3% from 2023). The average cost per claim was $182.20.
Texas had the highest Medicare cost for Insulin Lispro Kwikpen U-100 in 2024: $11.5M for 57,698 claims, followed by New York ($11.3M).
Krishnakumar Rajamani, endocrinology in Rochester, NY, had the highest Medicare cost for Insulin Lispro Kwikpen U-100 in 2024: 404 claims costing $134K.
Insulin Lispro Kwikpen U-100 is made by Eli Lilly and Company (LLY), listed in the Medicare spending data as Eli Lilly & Co..
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Krishnakumar Rajamani Rochester, NY | Endocrinology | 404 | 138 | $134K |
| Vishal Bhatia Evansville, IN | Endocrinology | 131 | 76 | $110K |
| Maryanne Stahlecker-Etter |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 96,399 | 606,990 | 198,735 | $122.8M |
| 2023 | 102,943 | 654,088 | 215,181 | $129.4M |
| 2024 | 126,132 | 847,337 | 283,389 | $154.4M |
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Nurse Practitioner |
| 443 |
| 143 |
| $107K |
| Robert Bingham Rochester, NY | Endocrinology | 301 | 93 | $105K |
| Michael W Quartuccio Rochester, NY | Endocrinology | 239 | 111 | $99K |
| Jane M Bridges Vincennes, IN | Family Practice | 221 | 61 | $91K |
| Jasjeet Kaur Glendale, AZ | Endocrinology | 246 | 57 | $88K |
| Vasdev Lohano Washington, IN | Endocrinology | 264 | 89 | $80K |
| Kaye Pamela Y Zozobrado Rochester, NY | Endocrinology | 173 | 74 | $77K |
| Ahmed F Al Jebawi Anderson, IN | Endocrinology | 245 | 65 | $76K |
| Timothy J Shoemaker Greenwood, IN | Internal Medicine | 172 | 64 | $71K |
| Hisham A Alrefai Louisville, KY | Internal Medicine | 159 | 68 | $69K |
| Angela N Perez Temple, TX | Nurse Practitioner | 110 | 56 | $67K |
| Seth S Charatz Rochester, NY | Endocrinology | 223 | 85 | $66K |
| Saleh Khaddash Clifton, NJ | Endocrinology | 333 | 88 | $66K |
| Junping Yang Saint Joseph, MO | Endocrinology | 134 | 58 | $66K |
| Luis F Chavez Rochester, NY | Endocrinology | 236 | 83 | $62K |
| Kristyl J Woolsey Little Rock, AR | Nurse Practitioner | 226 | 68 | $61K |
| Najmuddin K Karimjee Houston, TX | Internal Medicine | 110 | 41 | $61K |
| Anant Jeet Lorain, OH | Endocrinology | 211 | 57 | $59K |
| Salman M Azim Rochester, NY | Endocrinology | 195 | 70 | $57K |
| Heather M Hazelwood Cedar Rapids, IA | Nurse Practitioner | 114 | 49 | $57K |
| Juliet Wong Rochester, NY | Nurse Practitioner | 252 | 71 | $56K |
| Elizabeth Tape Seymour, IN | Nurse Practitioner | 165 | 49 | $55K |
| Jennifer M Lavare Sidney, NY | Nurse Practitioner | 165 | 78 | $54K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Eli Lilly & Co. LLY | 847,641 | $154.4M |